在患有静脉血栓栓塞性疾病的患者中增加了血小板粘附性
Julia Martinez-Sanchez1,2, Sergi Torramade-Moix1, Ana Belén Moreno-Castaño1,2
1Department of Pathology, Hemostasis and Erythropathology Laboratory, Hematopathology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
TH open : companion journal to thrombosis and haemostasis
|December 2, 2024
概括
来自静脉血栓栓塞病 (VTE) 患者的血小板在流动下增强粘附,这与较高的ZAP70/SYK72酸化和·维勒布兰德因子 (VWF) 水平有关. 这种增强的血小板功能有助于VTE的发展.
科学领域:
- 血液学 血液学 血液学
- 心血管生物学 心血管生物学
- 血栓形成研究研究
背景情况:
- 血小板功能在静脉血栓栓塞性疾病 (VTE) 中的作用已被认可,但除了聚合之外的机制,特别是血小板粘附性,仍未得到充分探索.
- 以前的研究表明,全球血小板功能与VTE风险之间存在关联,但对VTE患者的血小板粘合性质缺乏系统评估.
研究的目的:
- 系统地评估和描述VTE患者的血小板粘合功能.
- 调查潜在的分子机制,包括血小板内信号传递和血因素,有助于改变VTE的血小板粘附.
主要方法:
- 来自静脉瘤患者和健康对照者的全血样本使用多种测定方法进行了分析:PFA-100,圆板分析仪 (CPA) 和在流动条件下的微流体装置.
- 血小板粘附度,总体大小和表面覆盖率被量化. 评估了膜糖蛋白分析和血小板内信号传递 (ZAP70/SYK72酸化).
- 测量了维莱布兰德因子 (VWF) 抗原和ADAMTS-13活性的血水平.
主要成果:
- 与对照组相比,VTE患者在PFA-100上表现出明显更短的关闭时间.
- 在流动条件下,在VTE患者中观察到血小板总体尺寸 (CPA) 的增加和附着力的增强 (覆盖面积更高, I型原的总体体积增加).
- 在VTE患者中发现了高血小板内ZAP70/SYK72酸化和显著更高的血VWF水平.
结论:
- 来自VTE患者的血小板表现出一种亲粘性表型,特别是在流动条件下,有助于缩短PFA-100封闭时间.
- 在VTE中增强的血小板粘附性可能是由增加的血小板内ZAP70/SYK72信号传递和高血VWF水平的介导.
- 这些发现凸显了初级血液静止和血小板粘附在VTE病理生理学中的重要作用.
更多相关视频
相关概念视频
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Introduction to Hemostasis
5.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.6K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K


